A progress tracker is a tempting shortcut. Find a company, find a status, and move on. With food-dye pledges, the most useful information may sit in the description beside the status.
FDA's industry tracker, retrieved October 20, lists company commitments, the products covered, planned changes and statuses including complete and in progress. Its rows differ in scope: some concern specified products or channels, while others cover broader portfolios. The page also discusses regulatory actions. A voluntary commitment and a legal requirement should not be collapsed into the same claim.
Give the achievement its actual size
Dex's commentary: A label can be perfectly accurate and still be read too broadly. If the stated commitment covers a defined set of products, completion should be understood within that boundary. It should not quietly expand to every item a company sells, every country where it operates or every possible ingredient concern.
A hypothetical example makes the reading task easier. Suppose a pledge covers one product line made after a specified date. To evaluate it, a reader would need that product definition and date before interpreting a completed status. This is an invented example of how to read a claim, not an allegation about a named company in FDA's table.
The same discipline works in the other direction. An in-progress status does not, by itself, establish that nothing has changed. A fair assessment would ask what the commitment promised, what had been completed by the relevant date, and what evidence supported the status. The table is a starting point for that inquiry, not permission to fill missing details with suspicion.
Keep the law in its own column
FDA's explanation of color-additive regulation describes an approval system tied to intended uses, listing requirements and, for certain additives, batch certification. That is a different kind of record from a company's announced reformulation goal. Reading an individual legal claim requires the applicable rule, use and effective date.
This article does not supply a complete legal inventory or determine a particular product's compliance. It also does not evaluate the health effects of every color additive or its replacement. A manufacturing change, a regulatory decision and a demonstrated health outcome each require their own evidence.
The distinction matters for an ordinary shopping question too. A statement about color additives answers a question about color additives. It does not automatically answer every other question a household may have about a food. Stretching one claim into a universal verdict makes the message simpler and the reasoning worse.
A useful classroom exercise needs no laboratory
Choose a public commitment and write down its subject, scope, deadline and evidence. Then try rewriting it in one sentence without losing any of those four parts. If the sentence becomes too long, simplify the wording before deleting a boundary that changes the meaning.
That is a TiPH media-literacy exercise, not a compliance inspection. Students should not pretend a website review substitutes for testing a product or checking a factory. They can, however, learn the valuable skill of seeing what a public claim does and does not establish.
For readers exploring food-system careers, this is part of the work behind responsible communication. Technical specialists, regulators, programme evaluators and writers all need descriptions that preserve the unit being measured. A number or badge is easier to share when it is short; it is more useful when it stays true to its scope.
Fact: FDA publishes a tracker with defined commitments and statuses. Analysis: Read the scope alongside the status and separate pledges from rules. Uncertainty: TiPH has not independently verified company implementation, laboratory composition, product availability or health outcomes. This is commentary on interpreting the public record.
How we reported this
AI-assisted review of FDA's pledge tracker and regulatory explainer, retrieved October 20. No company interviews, product tests, enforcement review or original nutritional analysis were conducted. No individual company is accused of noncompliance. The hypothetical example and reading exercise are TiPH analysis. See our signal methodology for the same habit of keeping definitions and dates attached.
Persona and AI disclosure: Dex Mercer is a recurring fictional TiPH editorial pen-name, not a real individual or expert source. No credentials, access or lived experience are implied. This AI-assisted article was prepared for publication at Elijah St. John's request for the October 20 edition. Publication authorization does not imply that the persona conducted interviews or independent testing.
Corrections: Report errors through TiPH's About page. Material corrections and updates will receive a dated explanation under the Corrections Policy.
Related on TiPH: Global Signal Scan, October 20, 2026 · Latest news · How we verify signals